← Leaderboards
James A Posey
University Of Alabama At Birmingham
$1,592,192
Attributed
$1,592,192
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,592,192 · 7
By mechanism
M01$965,219 · 6
K23$626,973 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Bernard Roizman$20,026,247
- Thomas M. Lincoln$6,405,130
- Xun Ai$9,859,591
- Narendra Wajapeyee$10,700,120
- A Brent Carter$10,705,460
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHuman Therapy EvaluationAntineoplasticsNeoplasm /Cancer ChemotherapyDosageBreast NeoplasmsDrug Screening /EvaluationClinical TrialsVitronectinClinical Trial Phase IMetastasisMonoclonal AntibodyNeoplastic GrowthPharmacokineticsNeoplastic CellAngiogenesis InhibitorsNeoplasm /Cancer ImmunotherapyDrug Delivery SystemsBacterial ToxinsPaclitaxelCombination ChemotherapyAdenocarcinomaTopotecan
Grant awards (15)
UAB 0282 GEMCITABINE$92,591
M01 · FY2006 · RR · contact PI
MENTORED PATIENT ORIENTED RESEARCH CAREER DEVELOPMENT AW$126,711
K23 · FY2004 · RR
Rebeccamycin in hepatabiliary cancers$83,017
M01 · FY2004 · RR
MENTORED PATIENT ORIENTED RESEARCH CAREER DEVELOPMENT AW$126,711
K23 · FY2003 · RR
TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES$175,256
M01 · FY2002 · RR
PNU 214936 IN ADVANCED ADENOCARCINOMAS OF THE BREAST$175,256
M01 · FY2002 · RR
MENTORED PATIENT ORIENTED RESEARCH CAREER DEVELOPMENT AW$126,711
K23 · FY2002 · RR
PNU 214936 IN ADVANCED ADENOCARCINOMAS OF THE BREAST$175,256
M01 · FY2001 · RR
TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES$175,256
M01 · FY2001 · RR
MENTORED PATIENT ORIENTED RESEARCH CAREER DEVELOPMENT AW$125,514
K23 · FY2001 · RR
MENTORED PATIENT ORIENTED RESEARCH CAREER DEVELOPMENT AW$121,326
K23 · FY2000 · RR
PNU 214936 IN ADVANCED ADENOCARCINOMAS OF THE BREAST$29,529
M01 · FY2000 · RR
TAXOTERE W/ CONTINUOUS INFUSION TOPOTECAN IN ADVANCED MALIGNANCIES$29,529
M01 · FY2000 · RR
ANTIVITRONECTIN RECEPTOR HUMANIZED MONOCLONAL ANTIBODY IN METASTATIC CANCER$29,529
M01 · FY2000 · RR
GEM 231 INFUSION IN PATIENTS WITH REFRACTORY SOLID TUMORS$0
M01 · FY2000 · RR